241 related articles for article (PubMed ID: 29316982)
1. The tankyrase inhibitor G007-LK inhibits small intestine LGR5
Norum JH; Skarpen E; Brech A; Kuiper R; Waaler J; Krauss S; Sørlie T
Biol Res; 2018 Jan; 51(1):3. PubMed ID: 29316982
[TBL] [Abstract][Full Text] [Related]
2. A novel tankyrase small-molecule inhibitor suppresses APC mutation-driven colorectal tumor growth.
Lau T; Chan E; Callow M; Waaler J; Boggs J; Blake RA; Magnuson S; Sambrone A; Schutten M; Firestein R; Machon O; Korinek V; Choo E; Diaz D; Merchant M; Polakis P; Holsworth DD; Krauss S; Costa M
Cancer Res; 2013 May; 73(10):3132-44. PubMed ID: 23539443
[TBL] [Abstract][Full Text] [Related]
3. Structure, Dynamics, and Functionality of Tankyrase Inhibitor-Induced Degradasomes.
Thorvaldsen TE; Pedersen NM; Wenzel EM; Schultz SW; Brech A; Liestøl K; Waaler J; Krauss S; Stenmark H
Mol Cancer Res; 2015 Nov; 13(11):1487-501. PubMed ID: 26124443
[TBL] [Abstract][Full Text] [Related]
4. Pharmacological inhibition of tankyrase induces bone loss in mice by increasing osteoclastogenesis.
Fujita S; Mukai T; Mito T; Kodama S; Nagasu A; Kittaka M; Sone T; Ueki Y; Morita Y
Bone; 2018 Jan; 106():156-166. PubMed ID: 29055830
[TBL] [Abstract][Full Text] [Related]
5. Structural basis and SAR for G007-LK, a lead stage 1,2,4-triazole based specific tankyrase 1/2 inhibitor.
Voronkov A; Holsworth DD; Waaler J; Wilson SR; Ekblad B; Perdreau-Dahl H; Dinh H; Drewes G; Hopf C; Morth JP; Krauss S
J Med Chem; 2013 Apr; 56(7):3012-23. PubMed ID: 23473363
[TBL] [Abstract][Full Text] [Related]
6. Lgr5-expressing stem cells are not the cells of origin of pyloric neuroendocrine carcinomas in mice.
Vetter E; Kronast M; Tölge M; Zimmermann W
J Pathol; 2016 Jan; 238(1):42-51. PubMed ID: 26333534
[TBL] [Abstract][Full Text] [Related]
7. Tankyrases maintain homeostasis of intestinal epithelium by preventing cell death.
Ye P; Chiang YJ; Qi Z; Li Y; Wang S; Liu Y; Li X; Chen YG
PLoS Genet; 2018 Sep; 14(9):e1007697. PubMed ID: 30260955
[TBL] [Abstract][Full Text] [Related]
8. Tankyrase inhibition sensitizes melanoma to PD-1 immune checkpoint blockade in syngeneic mouse models.
Waaler J; Mygland L; Tveita A; Strand MF; Solberg NT; Olsen PA; Aizenshtadt A; Fauskanger M; Lund K; Brinch SA; Lycke M; Dybing E; Nygaard V; Bøe SL; Heintz KM; Hovig E; Hammarström C; Corthay A; Krauss S
Commun Biol; 2020 Apr; 3(1):196. PubMed ID: 32332858
[TBL] [Abstract][Full Text] [Related]
9. RK-287107, a potent and specific tankyrase inhibitor, blocks colorectal cancer cell growth in a preclinical model.
Mizutani A; Yashiroda Y; Muramatsu Y; Yoshida H; Chikada T; Tsumura T; Okue M; Shirai F; Fukami T; Yoshida M; Seimiya H
Cancer Sci; 2018 Dec; 109(12):4003-4014. PubMed ID: 30238564
[TBL] [Abstract][Full Text] [Related]
10. Arsenic exposure in drinking water reduces Lgr5 and secretory cell marker gene expression in mouse intestines.
Jatko JT; Darling CL; Kellett MP; Bain LJ
Toxicol Appl Pharmacol; 2021 Jul; 422():115561. PubMed ID: 33957193
[TBL] [Abstract][Full Text] [Related]
11. The PARsylation activity of tankyrase in adipose tissue modulates systemic glucose metabolism in mice.
Zhong L; Ding Y; Bandyopadhyay G; Waaler J; Börgeson E; Smith S; Zhang M; Phillips SA; Mahooti S; Mahata SK; Shao J; Krauss S; Chi NW
Diabetologia; 2016 Mar; 59(3):582-91. PubMed ID: 26631215
[TBL] [Abstract][Full Text] [Related]
12. mTOR signaling mediates resistance to tankyrase inhibitors in Wnt-driven colorectal cancer.
Mashima T; Taneda Y; Jang MK; Mizutani A; Muramatsu Y; Yoshida H; Sato A; Tanaka N; Sugimoto Y; Seimiya H
Oncotarget; 2017 Jul; 8(29):47902-47915. PubMed ID: 28615517
[TBL] [Abstract][Full Text] [Related]
13. A Small-Molecule Tankyrase Inhibitor Reduces Glioma Stem Cell Proliferation and Sphere Formation.
Kierulf-Vieira KS; Sandberg CJ; Waaler J; Lund K; Skaga E; Saberniak BM; Panagopoulos I; Brandal P; Krauss S; Langmoen IA; Vik-Mo EO
Cancers (Basel); 2020 Jun; 12(6):. PubMed ID: 32575464
[TBL] [Abstract][Full Text] [Related]
14. Differential Roles of AXIN1 and AXIN2 in Tankyrase Inhibitor-Induced Formation of Degradasomes and β-Catenin Degradation.
Thorvaldsen TE; Pedersen NM; Wenzel EM; Stenmark H
PLoS One; 2017; 12(1):e0170508. PubMed ID: 28107521
[TBL] [Abstract][Full Text] [Related]
15. Identification of stem cells in small intestine and colon by marker gene Lgr5.
Barker N; van Es JH; Kuipers J; Kujala P; van den Born M; Cozijnsen M; Haegebarth A; Korving J; Begthel H; Peters PJ; Clevers H
Nature; 2007 Oct; 449(7165):1003-7. PubMed ID: 17934449
[TBL] [Abstract][Full Text] [Related]
16. Foxf2 in intestinal fibroblasts reduces numbers of Lgr5(+) stem cells and adenoma formation by inhibiting Wnt signaling.
Nik AM; Reyahi A; Pontén F; Carlsson P
Gastroenterology; 2013 May; 144(5):1001-11. PubMed ID: 23376422
[TBL] [Abstract][Full Text] [Related]
17. Tankyrase inhibitors suppress hepatocellular carcinoma cell growth via modulating the Hippo cascade.
Jia J; Qiao Y; Pilo MG; Cigliano A; Liu X; Shao Z; Calvisi DF; Chen X
PLoS One; 2017; 12(9):e0184068. PubMed ID: 28877210
[TBL] [Abstract][Full Text] [Related]
18. Tankyrase disrupts metabolic homeostasis and promotes tumorigenesis by inhibiting LKB1-AMPK signalling.
Li N; Wang Y; Neri S; Zhen Y; Fong LWR; Qiao Y; Li X; Chen Z; Stephan C; Deng W; Ye R; Jiang W; Zhang S; Yu Y; Hung MC; Chen J; Lin SH
Nat Commun; 2019 Sep; 10(1):4363. PubMed ID: 31554794
[TBL] [Abstract][Full Text] [Related]
19. CD44 and TLR4 mediate hyaluronic acid regulation of Lgr5+ stem cell proliferation, crypt fission, and intestinal growth in postnatal and adult mice.
Riehl TE; Santhanam S; Foster L; Ciorba M; Stenson WF
Am J Physiol Gastrointest Liver Physiol; 2015 Dec; 309(11):G874-87. PubMed ID: 26505972
[TBL] [Abstract][Full Text] [Related]
20. Regeneration of intestinal stem/progenitor cells following doxorubicin treatment of mice.
Dekaney CM; Gulati AS; Garrison AP; Helmrath MA; Henning SJ
Am J Physiol Gastrointest Liver Physiol; 2009 Sep; 297(3):G461-70. PubMed ID: 19589945
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
